HOSPIRA INC
DelistedCIK 1274057fmd_1WXSH4X3HXJR7BH0K6JJS3FRARManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2007 to Jun 30, 2015, 30 periods
| Line item | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|---|---|---|
| Cost of revenue | 2,241 | 2,287 | 2,423 | 2,403 | 2,660 | 2,979 | 2,922 | 2,877 |
| Research and development | 201 | 212 | 241 | 301 | 259 | 304 | 302 | 344 |
| Selling, general and administrative | 582 | 590 | 619 | 675 | 637 | 688 | 743 | 841 |
| Operating income | 303 | 518 | 503 | 519 | 57 | 59 | 17 | 466 |
| Interest expense | 135 | 116 | 106 | 101 | 93 | 86 | 86 | 77 |
| Interest and investment income | – | – | – | – | – | 6 | 5 | 7 |
| Other non-operating income (expense) | 20 | 6 | (13) | (39) | 9 | (14) | (54) | (1) |
| Income before taxes | – | 408 | 384 | 379 | (27) | (42) | (123) | 388 |
| Income tax expense | 51 | 87 | (19) | 34 | 28 | (51) | (98) | 72 |
| Net income from continuing operations | – | 321 | 403 | 345 | (55) | 9 | (25) | 316 |
| Net income | 137 | 321 | 404 | 357 | – | – | – | – |
| Net income to common shareholders | – | – | 404 | 357 | (9) | 44 | (8) | 333 |